4.3 Article

Risk Analysis of Aneurysm Sac Enlargement Caused by Type II Endoleak after Endovascular Aortic Repair

Journal

ANNALS OF VASCULAR SURGERY
Volume 77, Issue -, Pages 208-216

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.avsg.2021.06.013

Keywords

-

Ask authors/readers for more resources

Chronic kidney disease stage >= 4, patent inferior mesenteric artery (IMA), and number of patent lumbar arteries (LAs) were identified as independent risk factors for aneurysm sac enlargement after EVAR. Among these, patent IMA had the highest hazard ratio and appeared to have the greatest impact on long-term sac enlargement. Taking preoperative measures to address a patent IMA may be important in reducing the incidence of sac enlargement.
Background: Although the preoperative risk factors associated with the occurrence of type II endoleak (ETII) after endovascular aortic repair (EVAR) have gradually become more evident, the preoperative risk factors associated with aneurysm sac enlargement caused by ETII remain unclear. This study aimed to determine the preoperative risk factors associated with aneurysm sac enlargement caused by ETII after EVAR. Methods: This retrospective cohort study reviewed 519 EVARs performed for true abdominal aortic aneurysm between January 2006 and December 2018 at our institution. EVARs using commercially available bifurcated devices with no type I or III endoleaks during follow-up and with >= 12 months follow-up were included. A total of 320 patients were enrolled in the study. To identify the preoperative risk factors of sac enlargement after EVAR, Cox regression analysis was used to assess preoperative data. Results: The median follow-up period was 60.8 months. Overall, 135 of 320 patients (42%) had ETII during follow-up, and 47 of 135 patients (35%) developed aneurysm sac enlargement. Multivariate analysis revealed that chronic kidney disease (CKD) stage >= 4 (hazard ratio [HR], 4.65; 95% confidence interval [CI], 2.13-10.15; P = 0.001), patent inferior mesenteric artery (IMA) (HR, 17.85; 95% CI, 2.46-129.73; P < 0.001), and number of patent lumbar arteries (LAs) (HR, 1.37; 95% CI, 1.13-1.68; P= 0.002) were risk factors of aneurysm sac enlargement caused by ETII. Conclusions: CKD stage >= 4, patent IMA, and number of patent LAs were independent risk factors for aneurysm sac enlargement after EVAR. In particular, patent IMA had the highest HR and seemed to have the greatest impact on long-term aneurysm sac enlargement. Hence, taking preoperative measures to address a patent IMA appears to be important in reducing the incidence of sac enlargement.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Challenging endovascular treatment of a thoracic saccular aneurysm in extensive coral reef aorta

Toru Ide, Kenta Masada, Toru Kuratani, Kazuo Shimamura, Takayuki Shijo, Shigeru Miyagawa

Summary: This article presents a case of a female patient with a saccular aneurysm in the coral reef aorta (CRA), who underwent thoracic endovascular aortic repair (TEVAR). Despite encountering difficulties during the procedure, the aneurysm was successfully excluded.

JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES (2022)

Article Surgery

Impact of the Patency of Inferior Mesenteric Artery on 7-Year Outcomes After Endovascular Aneurysm Repair

Toru Ide, Kazuo Shimamura, Toru Kuratani, Takayuki Shijo, Ryoto Sakaniwa, Yoshiki Watanabe, Koichi Maeda, Kenta Masada, Kizuku Yamashita, Ryota Matsumoto, Shigeru Miyagawa

Summary: This study investigated the specific impact of preoperative patent inferior mesenteric artery (IMA) on 7-year outcomes after endovascular aneurysm repair (EVAR). The results showed that IMA patency could affect late reintervention and aneurysm sac enlargement but did not have a significant impact on mortality. Preoperative assessment and embolization of IMA might be an important factor for improvement in late EVAR outcomes.

JOURNAL OF ENDOVASCULAR THERAPY (2022)

Article Surgery

Impact of Patent Lumbar Arteries on Aneurysm Sac Enlargement with Type II Endoleak after Endovascular Aneurysm Repair

Toru Ide, Kazuo Shimamura, Takayuki Shijo, Toru Kuratani, Ryoto Sakaniwa, Shigeru Miyagawa

Summary: This study investigated the impact of the number of patent lumbar arteries (LAs) on sac enlargement after endovascular aneurysm repair (EVAR). The results showed that when the inferior mesenteric artery (IMA) was patent pre-operatively, a high number of patent LAs significantly promoted sac enlargement with type II endoleak (T2EL). However, when the IMA was occluded pre-operatively, a high number of patent LAs had limited influence on sac enlargement.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2023)

Article Surgery

Diabetes, Hypertension, and Smoking Do Not Affect Outcomes of Iliofemoral Vein Stenting for Chronic Proximal Venous Outflow Obstruction

Yeju Kang, Halbert Bai, Jason B. Storch, Jenny Chen, Pavel Kibrik, Windsor Ting

Summary: Diabetes, hypertension, and smoking were common among CVI patients, but unlike in PAD patients, they had little to no impact on long-term outcomes or reinterventions after IVS.

ANNALS OF VASCULAR SURGERY (2024)